Abstract
This report evaluates the macitentan for the treatment of pulmonary arterial hypertension as part of a study, which evaluated the efficacy and safety of this drug against a placebo.
Keywords
Macitentan; Pulmonary arterial pressure; Drugs
Bibliographic citation
Comitè d’Avaluació de Medicaments d’Ús Hospitalari (CAMUH). Macitentan (Opsumit®) per al tractament de la hipertensió arterial pulmonar. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya; 2015. (Informes CAMUH).
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/2134This item appears in following collections
The following license files are associated with this item: